Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 213

1.

Changes in microparticle profiles by vitamin D receptor activation in chronic kidney disease - a randomized trial.

Lundwall K, Mörtberg J, Mobarrez F, Jacobson SH, Jörneskog G, Spaak J.

BMC Nephrol. 2019 Aug 1;20(1):290. doi: 10.1186/s12882-019-1445-4.

2.

Health-related quality of life as predictor of mortality in end-stage renal disease patients: an observational study.

Pei M, Aguiar R, Pagels AA, Heimbürger O, Stenvinkel P, Bárány P, Medin C, Jacobson SH, Hylander B, Lindholm B, Qureshi AR.

BMC Nephrol. 2019 Apr 29;20(1):144. doi: 10.1186/s12882-019-1318-x.

3.

Increased concentrations of platelet- and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function- a descriptive study.

Mörtberg J, Lundwall K, Mobarrez F, Wallén H, Jacobson SH, Spaak J.

BMC Nephrol. 2019 Mar 1;20(1):71. doi: 10.1186/s12882-019-1261-x.

4.

Achievement of renal anemia KDIGO targets by two different clinical strategies - a European hemodialysis multicenter analysis.

Drozdz M, Weigert A, Silva F, Frazão J, Alsuwaida A, Krishnan M, Kleophas W, Brzosko S, Johansson FK, Jacobson SH.

BMC Nephrol. 2019 Jan 7;20(1):5. doi: 10.1186/s12882-018-1196-7.

5.

Gradual reduction in exercise capacity in chronic kidney disease is associated with systemic oxygen delivery factors.

Wallin H, Asp AM, Wallquist C, Jansson E, Caidahl K, Hylander Rössner B, Jacobson SH, Rickenlund A, Eriksson MJ.

PLoS One. 2018 Dec 19;13(12):e0209325. doi: 10.1371/journal.pone.0209325. eCollection 2018.

6.

Treating endothelial dysfunction with vitamin D in chronic kidney disease: a meta-analysis.

Lundwall K, Jacobson SH, Jörneskog G, Spaak J.

BMC Nephrol. 2018 Sep 25;19(1):247. doi: 10.1186/s12882-018-1042-y.

7.

Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Al Salmi I, Larkina M, Wang M, Subramanian L, Morgenstern H, Jacobson SH, Hakim R, Tentori F, Saran R, Akiba T, Tomilina NA, Port FK, Robinson BM, Pisoni RL.

Am J Kidney Dis. 2018 Nov;72(5):634-643. doi: 10.1053/j.ajkd.2018.04.019. Epub 2018 Aug 23.

8.

Association between serum ferritin and mortality: findings from the USA, Japan and European Dialysis Outcomes and Practice Patterns Study.

Karaboyas A, Morgenstern H, Pisoni RL, Zee J, Vanholder R, Jacobson SH, Inaba M, Loram LC, Port FK, Robinson BM.

Nephrol Dial Transplant. 2018 Dec 1;33(12):2234-2244. doi: 10.1093/ndt/gfy190.

9.

Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.

Wallquist C, Mansouri L, Norrbäck M, Hylander B, Jacobson SH, Larsson TE, Lundahl J.

Nephron. 2018;138(4):287-295. doi: 10.1159/000485472. Epub 2018 Jan 4.

PMID:
29301137
10.

Mortality risk in patients on hemodiafiltration versus hemodialysis: a 'real-world' comparison from the DOPPS.

Locatelli F, Karaboyas A, Pisoni RL, Robinson BM, Fort J, Vanholder R, Rayner HC, Kleophas W, Jacobson SH, Combe C, Port FK, Tentori F.

Nephrol Dial Transplant. 2018 Apr 1;33(4):683-689. doi: 10.1093/ndt/gfx277.

11.

Random Acts of Violence? Examining Probabilistic Independence of the Temporal Distribution of Mass Killing Events in the United States.

King DM, Jacobson SH.

Violence Vict. 2017 Dec 1;32(6):1014-1023. doi: 10.1891/0886-6708.VV-D-16-00039. Epub 2017 Oct 10.

PMID:
29017642
12.

Altered basophil function in patients with chronic kidney disease on hemodialysis
.

Aljadi Z, Nopp A, Winqvist O, Russom A, Hylander B, Jacobson SH, Lundahl J.

Clin Nephrol. 2017 Aug;88(8):86-96. doi: 10.5414/CN108992.

PMID:
28655384
13.

Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.

Mansouri L, Lundwall K, Moshfegh A, Jacobson SH, Lundahl J, Spaak J.

BMC Nephrol. 2017 May 16;18(1):161. doi: 10.1186/s12882-017-0576-8.

14.

Aspects of carotid structure and function in health and different stages of chronic kidney disease.

Asp AM, Wallquist C, Rickenlund A, Hylander B, Jacobson SH, Caidahl K, Eriksson MJ.

Clin Physiol Funct Imaging. 2018 May;38(3):402-408. doi: 10.1111/cpf.12429. Epub 2017 Apr 16.

PMID:
28419771
15.

Hemodialysis Patients Display a Declined Proportion of Th2 and Regulatory T Cells in Parallel with a High Interferon-γ Profile.

Mansouri L, Nopp A, Jacobson SH, Hylander B, Lundahl J.

Nephron. 2017;136(3):254-260. doi: 10.1159/000471814. Epub 2017 Apr 6.

PMID:
28380480
16.

Analyzing the impact of public transit usage on obesity.

She Z, King DM, Jacobson SH.

Prev Med. 2017 Jun;99:264-268. doi: 10.1016/j.ypmed.2017.03.010. Epub 2017 Mar 16.

PMID:
28322880
17.

What Is Driving Obesity? A Review on the Connections Between Obesity and Motorized Transportation.

King DM, Jacobson SH.

Curr Obes Rep. 2017 Mar;6(1):3-9. doi: 10.1007/s13679-017-0238-y. Review.

PMID:
28243840
18.

Systematic underutilisation of secondary preventive drugs in patients with acute coronary syndrome and reduced renal function.

Khedri M, Szummer K, Carrero JJ, Jernberg T, Evans M, Jacobson SH, Spaak J.

Eur J Prev Cardiol. 2017 May;24(7):724-734. doi: 10.1177/2047487317693950. Epub 2017 Feb 14.

PMID:
28195517
19.

Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.

Eriksson JK, Neovius M, Jacobson SH, Elinder CG, Hylander B.

BMJ Open. 2016 Oct 7;6(10):e012062. doi: 10.1136/bmjopen-2016-012062.

20.

Early Changes in Monocyte Adhesion Molecule Expression and Tumor Necrosis Factor-α Levels in Chronic Kidney Disease - A 5-Year Prospective Study.

Wallquist C, Mansouri L, Norrbäck M, Hylander B, Jacobson SH, Lundahl J.

Am J Nephrol. 2016;44(4):268-275. Epub 2016 Sep 8.

PMID:
27603798
21.

Initiation of erythropoiesis-stimulating agents and outcomes: a nationwide observational cohort study in anaemic chronic kidney disease patients.

Evans M, Carrero JJ, Bellocco R, Barany P, Qureshi AR, Seeberger A, Jacobson SH, Hylander-Rössner B, Rotnitzky A, Sjölander A.

Nephrol Dial Transplant. 2017 Nov 1;32(11):1892-1901. doi: 10.1093/ndt/gfw328.

PMID:
27672090
22.

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.

Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.

J Am Coll Cardiol. 2016 Apr 12;67(14):1687-97. doi: 10.1016/j.jacc.2016.01.050.

23.

A double-risk monitoring and movement restriction policy for Ebola entry screening at airports in the United States.

Jacobson SH, Yu G, Jokela JA.

Prev Med. 2016 Jul;88:33-8. doi: 10.1016/j.ypmed.2016.03.018. Epub 2016 Mar 19.

PMID:
27002253
24.

Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.

Mörtberg J, Blombäck M, Wallén Å, He S, Jacobson SH, Spaak J.

Blood Coagul Fibrinolysis. 2016 Jun;27(4):401-7. doi: 10.1097/MBC.0000000000000462.

PMID:
26650459
25.

International Comparisons to Assess Effects of Payment and Regulatory Changes in the United States on Anemia Practice in Patients on Hemodialysis: The Dialysis Outcomes and Practice Patterns Study.

Fuller DS, Bieber BA, Pisoni RL, Li Y, Morgenstern H, Akizawa T, Jacobson SH, Locatelli F, Port FK, Robinson BM.

J Am Soc Nephrol. 2016 Jul;27(7):2205-15. doi: 10.1681/ASN.2015060673. Epub 2015 Nov 18.

26.

Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.

Lundwall K, Jörneskog G, Jacobson SH, Spaak J.

Am J Nephrol. 2015;42(4):265-73. doi: 10.1159/000441364. Epub 2015 Oct 24.

PMID:
26496210
27.

Effects of lipid-lowering treatment on circulating microparticles in patients with diabetes mellitus and chronic kidney disease.

Almquist T, Mobarrez F, Jacobson SH, Wallén H, Hjemdahl P.

Nephrol Dial Transplant. 2016 Jun;31(6):944-52. doi: 10.1093/ndt/gfv337. Epub 2015 Sep 22.

PMID:
26394646
28.

End of life of patients treated with haemodialysis as narrated by their close relatives.

Axelsson L, Klang B, Lundh Hagelin C, Jacobson SH, Gleissman SA.

Scand J Caring Sci. 2015 Dec;29(4):776-84. doi: 10.1111/scs.12209. Epub 2015 Mar 9.

PMID:
25754028
29.

Association between the use of fondaparinux vs low-molecular-weight heparin and clinical outcomes in patients with non-ST-segment elevation myocardial infarction.

Szummer K, Oldgren J, Lindhagen L, Carrero JJ, Evans M, Spaak J, Edfors R, Jacobson SH, Andell P, Wallentin L, Jernberg T.

JAMA. 2015 Feb 17;313(7):707-16. doi: 10.1001/jama.2015.517.

PMID:
25688782
30.

Recent changes in therapeutic approaches and association with outcomes among patients with secondary hyperparathyroidism on chronic hemodialysis: the DOPPS study.

Tentori F, Wang M, Bieber BA, Karaboyas A, Li Y, Jacobson SH, Andreucci VE, Fukagawa M, Frimat L, Mendelssohn DC, Port FK, Pisoni RL, Robinson BM.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):98-109. doi: 10.2215/CJN.12941213. Epub 2014 Dec 16.

31.

Analytics for vaccine economics and pricing: insights and observations.

Robbins MJ, Jacobson SH.

Expert Rev Vaccines. 2015 Apr;14(4):605-16. doi: 10.1586/14760584.2015.985662. Epub 2014 Dec 1. Review.

PMID:
25435003
32.

Associations of self-reported physical activity types and levels with quality of life, depression symptoms, and mortality in hemodialysis patients: the DOPPS.

Lopes AA, Lantz B, Morgenstern H, Wang M, Bieber BA, Gillespie BW, Li Y, Painter P, Jacobson SH, Rayner HC, Mapes DL, Vanholder RC, Hasegawa T, Robinson BM, Pisoni RL.

Clin J Am Soc Nephrol. 2014 Oct 7;9(10):1702-12. doi: 10.2215/CJN.12371213. Epub 2014 Oct 2.

33.

Seatbelt usage: is there an association with obesity?

Behzad B, King DM, Jacobson SH.

Public Health. 2014 Sep;128(9):799-803. doi: 10.1016/j.puhe.2014.06.003. Epub 2014 Aug 31.

PMID:
25183564
34.

Exercise training in adults with CKD: a systematic review and meta-analysis.

Heiwe S, Jacobson SH.

Am J Kidney Dis. 2014 Sep;64(3):383-93. doi: 10.1053/j.ajkd.2014.03.020. Epub 2014 Jun 7. Review.

PMID:
24913219
35.

The relationship between pediatric combination vaccines and market effects.

Behzad B, Jacobson SH, Jokela JA, Sewell EC.

Am J Public Health. 2014 Jun;104(6):998-1004. doi: 10.2105/AJPH.2013.301780. Epub 2014 Apr 17.

36.

Meanings of being a close relative of a family member treated with haemodialysis approaching end of life.

Axelsson L, Klang B, Lundh Hagelin C, Jacobson SH, Gleissman SA.

J Clin Nurs. 2015 Feb;24(3-4):447-56. doi: 10.1111/jocn.12622. Epub 2014 May 9.

PMID:
24811430
37.

Cardiac remodelling and functional alterations in mild-to-moderate renal dysfunction: comparison with healthy subjects.

Asp AM, Wallquist C, Rickenlund A, Hylander B, Jacobson SH, Caidahl K, Eriksson MJ.

Clin Physiol Funct Imaging. 2015 May;35(3):223-30. doi: 10.1111/cpf.12154. Epub 2014 Apr 21.

38.

Lipid-lowering treatment and inflammatory mediators in diabetes and chronic kidney disease.

Almquist T, Jacobson SH, Mobarrez F, Näsman P, Hjemdahl P.

Eur J Clin Invest. 2014;44(3):276-84. doi: 10.1111/eci.12230. Epub 2014 Jan 22.

PMID:
24720535
39.

Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis.

Aljadi Z, Mansouri L, Nopp A, Paulsson JM, Winqvist O, Russom A, Ståhl M, Hylander B, Jacobson SH, Lundahl J.

Artif Organs. 2014 Nov;38(11):945-53. doi: 10.1111/aor.12297. Epub 2014 Apr 9.

40.

Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation.

Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T.

JAMA. 2014 Mar 5;311(9):919-28. doi: 10.1001/jama.2014.1334.

PMID:
24595776
41.

Mortality in chronic kidney disease and renal replacement therapy: a population-based cohort study.

Neovius M, Jacobson SH, Eriksson JK, Elinder CG, Hylander B.

BMJ Open. 2014 Feb 18;4(2):e004251. doi: 10.1136/bmjopen-2013-004251.

42.

Increased accumulation of CD16+ monocytes at local sites of inflammation in patients with chronic kidney disease.

Wallquist C, Paulson JM, Hylander B, Lundahl J, Jacobson SH.

Scand J Immunol. 2013 Dec;78(6):538-44. doi: 10.1111/sji.12115.

43.

Leukocyte proliferation and immune modulator production in patients with chronic kidney disease.

Mansouri L, Paulsson JM, Moshfegh A, Jacobson SH, Lundahl J.

PLoS One. 2013 Aug 9;8(8):e73141. doi: 10.1371/journal.pone.0073141. eCollection 2013.

44.

Activation of Wnt/β-catenin pathway in monocytes derived from chronic kidney disease patients.

Al-Chaqmaqchi HA, Moshfegh A, Dadfar E, Paulsson J, Hassan M, Jacobson SH, Lundahl J.

PLoS One. 2013 Jul 23;8(7):e68937. doi: 10.1371/journal.pone.0068937. Print 2013.

45.

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction.

Zitt E, Fouque D, Jacobson SH, Malberti F, Ryba M, Ureña P, Rix M, Dehmel B, Manamley N, Vervloet M.

Clin Kidney J. 2013 Jun;6(3):287-294. Epub 2013 Apr 11.

46.

Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population.

Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Lundström E, Fernström A, Alfredsson L, Jacobson SH, Padyukov L.

Hum Immunol. 2013 Aug;74(8):957-60. doi: 10.1016/j.humimm.2013.04.016. Epub 2013 Apr 27.

PMID:
23628389
47.

The relationship of NT-proBNP and dialysis parameters with outcome of incident haemodialysis patients: results from the membrane permeability outcome study.

Locatelli F, Hannedouche T, Martin-Malo A, Jacobson SH, Vanholder R, Ronco C, La Milia V, Lopez Gomez JM, Stefoni S, Maheut H, Klinger M, Krummel T, Dhondt A, Berdud I, Gauly A.

Blood Purif. 2013;35(1-3):216-23. doi: 10.1159/000347076. Epub 2013 Mar 28.

48.

Quantifying the association between obesity, automobile travel, and caloric intake.

Behzad B, King DM, Jacobson SH.

Prev Med. 2013 Feb;56(2):103-6. doi: 10.1016/j.ypmed.2012.11.022. Epub 2012 Dec 5.

PMID:
23219682
49.

Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary.

Behzad B, Jacobson SH, Sewell EC.

Expert Rev Vaccines. 2012 Oct;11(10):1189-97. doi: 10.1586/erv.12.97.

PMID:
23176652
50.

Vaccine pricing: how can we get it right?

Jacobson SH.

Expert Rev Vaccines. 2012 Oct;11(10):1163-5. doi: 10.1586/erv.12.95. No abstract available.

PMID:
23176647

Supplemental Content

Loading ...
Support Center